Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Impact of interventions on mpox transmission during the 2022 outbreak in Canada: a mathematical modeling study of three different cities

Fanyu Xiu, Carla Doyle, Jorge Luis Flores Anato, Jesse Knight, Linwei Wang, Joseph Cox, Daniel Grace, Trevor A. Hart, Terri Zhang, Shayna Skakoon-Sparling, Milada Dvorakova, Rita Shahin, Herveen Sachdeva, Nathan Lachowsky, Hind Sbihi, Darrell H.S. Tan, Michael A. Irvine, Sharmistha Mishra, View ORCID ProfileMathieu Maheu-Giroux
doi: https://doi.org/10.1101/2024.06.20.24309262
Fanyu Xiu
1Department of Epidemiology and Biostatistics, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carla Doyle
1Department of Epidemiology and Biostatistics, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Luis Flores Anato
1Department of Epidemiology and Biostatistics, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesse Knight
2MAP Centre for Urban Health Solutions, Unity Health Toronto, ON, Canada
3Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linwei Wang
2MAP Centre for Urban Health Solutions, Unity Health Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Cox
1Department of Epidemiology and Biostatistics, McGill University, Montréal, QC, Canada
4Research Institute of the McGill University Health Centre, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Grace
5Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trevor A. Hart
5Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
6Department of Psychology, Toronto Metropolitan University, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terri Zhang
6Department of Psychology, Toronto Metropolitan University, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shayna Skakoon-Sparling
6Department of Psychology, Toronto Metropolitan University, Toronto, ON, Canada
7Department of Psychology, University of Guelph, Guelph, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milada Dvorakova
4Research Institute of the McGill University Health Centre, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rita Shahin
5Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
8Toronto Public Health, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Herveen Sachdeva
5Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
8Toronto Public Health, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan Lachowsky
9School of Public Health and Social Policy, University of Victoria, Victoria, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hind Sbihi
10Data and Analytic Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada
11School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darrell H.S. Tan
3Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada
4Research Institute of the McGill University Health Centre, Montréal, QC, Canada
12Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Irvine
10Data and Analytic Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada
13Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada
14Department of Statistics, University of British Columbia, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharmistha Mishra
2MAP Centre for Urban Health Solutions, Unity Health Toronto, ON, Canada
3Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada
5Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
12Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathieu Maheu-Giroux
1Department of Epidemiology and Biostatistics, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mathieu Maheu-Giroux
  • For correspondence: mathieu.maheu-giroux{at}mcgill.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The 2022-2023 global mpox outbreak primarily affected gay, bisexual, and other men who have sex with men (GBM). It was met with swift community and public health responses. The relative impact of GBM’s reductions in sexual partners, contact tracing/isolation, and vaccination on transmission in Canadian cities remain unknown.

Methods We estimated changes in sexual behaviours during the outbreak using 2022 data from the Engage Cohort Study which recruited self-identified GBM in Montréal, Toronto, and Vancouver (n=1,445). The numbers of sexual partners in the past 6 months (P6M) were modeled using negative binomial regressions. A transmission-dynamic compartmental model was calibrated to surveillance data. We estimated the averted fraction of new infections attributable to reductions in sexual partners, contact tracing/isolation, and first-dose vaccination, versus an unmitigated epidemic scenario, in each of the three cities.

Results The empirical estimates of sexual behaviours changes were imprecise: 20% (RR=0.80; 95% credible intervals [95%CrI]: 0.47-1.36) fewer sexual partners among those reporting ≤7 partners (P6M) and 33% (RR=0.67; 95%CrI: 0.31-1.43) fewer among those with >7 partners (P6M). Compared to the unmitigated epidemics, we estimated that the three interventions combined avert 46%-58% of cases. Reductions in sexual partners, contact tracing/isolation prevented approximately 12% and 14% of cases, respectively. Vaccination’s effect varied across cities by start date and coverage, with 21%-39% mpox infections prevented.

Conclusions Reduction in sexual activity, contact tracing/isolation, and vaccination all contributed to accelerating epidemic control and infections averted. Early vaccination had the largest impact.

Competing Interest Statement

JC reports research grants from Gilead Sciences Canada and ViiV Healthcare, all outside of the submitted work. MM-G reports contractual arrangements from the World Health Organization, the Joint United Nations Programme on HIV/AIDS (UNAIDS), and the Public Health Agency of Canada, all outside of the submitted work. TAH reports educational grants from being an Advisory Committee member for the Canadian Institutes of Health Research (CIHR)'s Institute of Infection and Immunity and funds for community engagement events from ViiV Healthcare and Gilead Sciences Canada, all outside of the submitted work. DHST's institution has received investigator-initiated grants from Abbvie and Gilead, and support for participation in clinical trials sponsored by Glaxo Smith Kline. All other authors report no conflict of interest.

Funding Statement

This work was supported by the Canadian Network for Modelling Infectious Diseases (CANMOD) to SM, MI, and MM-G, grants from the Canadian Institutes of Health Research (CIHR, #495171) to MI, SM, HS, and MM-G, and grants from the University of Toronto Emerging Infections and Pandemic Consortium Mpox Rapid Research Response to SM and DHST. MM-G's research program is funded by a Canada Research Chair (Tier 2) in Population Health Modelling. FX acknowledges studentships from the McGill Center for Viral Diseases and the McGill Faculty of Medicine and Health Sciences. TAH received support from a Chair in Gay and Bisexual Men's Health from the Ontario HIV Treatment Network. SM's research program is funded by a Canada Research Chair (Tier 2, CRC Number 950-232643) in Mathematical Modelling and Program Science. DG's research program is funded by a Canada Research Chair (Tier 2) in Sexual and Gender Minority Health. DHST is supported by a Canada Research Chair (Tier 2) in HIV Prevention and STI Research. JK acknowledges support from the Natural Sciences and Engineering Research Council of Canada Doctoral Award. NL is supported with Scholar Awards from the Michael Smith Foundation for Health Research (#5209, #16863). SS-S is supported by a CIHR postdoctoral fellowship award. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Research Ethics Office of the Faculty of Medicine and Health Sciences at McGill University gave ethnical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present work are contained in the manuscript.

https://github.com/pop-health-mod/mpox-intervention

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted June 21, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Impact of interventions on mpox transmission during the 2022 outbreak in Canada: a mathematical modeling study of three different cities
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Impact of interventions on mpox transmission during the 2022 outbreak in Canada: a mathematical modeling study of three different cities
Fanyu Xiu, Carla Doyle, Jorge Luis Flores Anato, Jesse Knight, Linwei Wang, Joseph Cox, Daniel Grace, Trevor A. Hart, Terri Zhang, Shayna Skakoon-Sparling, Milada Dvorakova, Rita Shahin, Herveen Sachdeva, Nathan Lachowsky, Hind Sbihi, Darrell H.S. Tan, Michael A. Irvine, Sharmistha Mishra, Mathieu Maheu-Giroux
medRxiv 2024.06.20.24309262; doi: https://doi.org/10.1101/2024.06.20.24309262
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Impact of interventions on mpox transmission during the 2022 outbreak in Canada: a mathematical modeling study of three different cities
Fanyu Xiu, Carla Doyle, Jorge Luis Flores Anato, Jesse Knight, Linwei Wang, Joseph Cox, Daniel Grace, Trevor A. Hart, Terri Zhang, Shayna Skakoon-Sparling, Milada Dvorakova, Rita Shahin, Herveen Sachdeva, Nathan Lachowsky, Hind Sbihi, Darrell H.S. Tan, Michael A. Irvine, Sharmistha Mishra, Mathieu Maheu-Giroux
medRxiv 2024.06.20.24309262; doi: https://doi.org/10.1101/2024.06.20.24309262

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)